Article
Down-regulation of PCK2 enhanced the radioresistance phenotype of nasopharyngeal carcinoma.
International journal of radiation biology - 1 Jan 2025
He Yijun, Yan Li, Zhang Ruiqi, Yang Rui, Kong Zhaolu, Wang Xiaosheng
Abstract excerpt
PURPOSE: Radiotherapy is the main treatment for non-distant metastatic nasopharyngeal carcinoma (NPC). However, about 15% of NPC patients still experience local tumor recurrence after radiotherapy. The mechanisms underlying the radioresistance of NPC have not been fully understood. This study explored the role of phosphoenolpyruvate carboxykinase2 (PCK2) in NPC radiosensitivity. METHODS: Two NPC cell lines,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
